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Objective: To study the effect of a reduction in  reimbursement of the cost of antibiotics on the prescribing pattern in  
primary care in Denmark. 
Method: We analyzed the general practitioners' prescriptions of antibiotics during 1993-96 in relation to  a reduction 
in reimbursement on the basis of national health service data in the county of North Jutland (population 488000). On 1 
January 1996 the reimbursement for tetracyclines was withdrawn, and for other antibiotics reimbursement was reduced 
from 75% to 50%. 
Results: The total consumption of all antibiotic groups increased steadily in the county until 1995, and in 1996 a 
decrease of 13% was seen. A very marked reduction was noticed immediately after 1 January 1996 for the more 
expensive broad-spectrum antibiotics. The use of tetracyclines dropped by 42% during the first 3 months of 1996 after 
withdrawal of reimbursement. 
Conclusions: It is reasonable to assume that the new reimbursement policy has initiated a reduction and caused a 
shift in general practitioners' prescribing of antibiotics. Thus a differential reimbursement policy might influence general 
practitioners' prescribing behavior towards antibiotics, with desirable ecological consequences. 
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INTRODUCTION care [2]. Thus, in the Scandinavian countries epidemic 
spread of penicilhn-resistant pneumococci, ampicdin- 
Increases in antibiotic resistance and spread of multi- resistant Huemopkilus inzuenzue and erythromyciii- 
resistant microorganisms are matters of increasing resistant group A streptococci has been linked to high 
concern worldwide. A high consumption of antibiotics local levels of antibiotic prescribing [3-51. 
has been identified as the decisive factor in this Antibiotics are not sold over the counter in 
development in the hospital setting [l], but there is Denmark, but have to be prescribed by a doctor. 
also compelling evidence of its importance in primary Denmark thus has the lowest use of antibiotics among 
the Nordic countries [6]. Approximately 90% of the 
antibiotics sold in Denmark are prescribed by general 
practitioners [7], and their level of prescribing has been 
shown to vary widely [S]. There are strong incentives 
to restrict the consumption of antibiotics in primary 
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care, and many methods for achieving this have been 
proposed [9]. One of these is the reimbursement policy, 
and on 1 January 1996 major reductions in reimburse- 
ment for antibiotics were put into force by the Danish 
653 
6 5 4  Cl in ica l  M i c r o b i o l o g y  and In fec t ion ,  Vo lume 3 Number  6, December 1997 
national health service. Since such attempts to control 
the use of antibiotics have great economic, ecological, 
and public-health implications, we analyzed the im- 
mediate effect of the reductions in reimbursement on 
the use of antibiotics in a Danish county with nearly 
500 000 inhabitants. 
MATERIALS AND METHODS 
The study was conducted in the county of North 
Jutland (population 488 000, approximately 9% of the 
total Danish population) from 1 January 1993 to 31 
December 1996. The national health service provides 
tax-supported health care for all inhabitants in the 
county. Besides free access to hospitals, specialists 
and general practitioners, the national health service 
rehnds part of the costs associated with most drugs on 
prescription. 
The county is served by 33 pharmacies, which 
are equipped with a computerized accounting system 
from which data are sent to the health insurance 
ahnistration of the Danish national health service. 
Antibiotics can only be purchased on prescription, and 
only drugs on prescription have their costs reimbursed 
by the health insurance program [ 101. The information 
in the accounting system includes the type of drug 
prescribed according to the anatomic therapeutic 
chemical (ATC) commodity number, amount of drug 
prescribed, the defined daily dose (DDD) [ 111, and date 
of purchase. A DDD is the average maintenance dose 
for the main indication of a particular drug and it allows 
a comparison between groups of antibiotics. 
Until 1 January 1996 a 75% reimbursement was 
provided for antibiotics, except for tetracyclines (50% 
reimbursement), and cephalosporins, chloramphenicol 
and sulfonamide in combination with trimethoprim, 
which were not subsidized. On 1 January 1996 the 
reimbursement for tetracyclines was withdrawn, and 
the reimbursement was reduced to 50% for all other 
subsidized antibiotics. The present study covered all 
prescriptions of antibiotics (ATC J O l ) ,  and the use of 
antibiotics in the county was calculated for each 3- 
month period &om 1993 to 1996. 
Table 1 Consumption of antibiotics (in defined daily doses) in the county of North Jutland &om 1993 to 1996 
Penicillins, Penicillins, Trimethoprim 
narrow broad and Fluoro- 
Tetracyclinesa spectrum' spectrum' sulfonamides' Macrohdes' quinolones' Cephalo- Total Increase 
(J01fW (J01CE) (J0 1 CA) (J01E) (J01FA) (JOlMA) sporins" (JOl) (%) 
1993 249537 688 473 639 694 137 809 279 766 44 425 3049 2087504 
1994 254585 709 566 653 960 150715 296 157 55 122 4135 2191319 4.7% 
1995 243331 721 587 647 205 143 135 310767 48 752 4119 2195631 0.2% 
1996 156898 688113 555 475 138 707 265 999 36 904 3853 1914943 -12.8% 
"Reimbursement withdrawn 1 January 1996. 'Reimbursement reduced from 75% to 50% 1 January 1996. 'Not subsidized 
ATC code in parenthesis. 
Table 2 Changes in consumption of antibiotics 1994-96 compared to the same period the year before (%) 
Penicillins, Penicillins, Trimethoprim and Fluoro- 
Tetracyclines" narrowspectrumh broad-spectrumh sulfonamides' Macrolides' quinolonesh Total 
(JO1'W (JolCE) (JOICA) (JOW (JOIFA) (J01MA) (JOl) 
1994-5 
1-3 months 5.2 6.8 10.8 -2.7 24.1 14.5 10.3 
4-6 months -1.8 1.1 -1.0 -3.8 4.8 -11.2 0.6 
7-9 months -11.3 -11.8 -15.7 -9.4 -13.4 -27.3 -12.7 
10-12 months -10.6 9.8 -1.4 -4.0 2.9 -19.6 1.2 
1995-1996 
1-3 months -42.2 6.6 -20.2 -7.6 -13.1 -41.9 -13.0 
4-6 months -33.5 2.1 -6.9 -0.9 -8.6 -23.0 -7.4 
7-9 months -26.5 -6.9 -4.8 -1.8 -7.7 1.7 -7.9 
10-12 months -37.0 -19.9 -19.6 -2.0 -24.7 -25.8 -20.5 
"Reimbursement withdrawn 1 January 1996. 'Reimbursement reduced from 75% to 50% 1 January 1996. 
ATC code in parentheses. 
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RESULTS 
The consumption of the different antibiotic groups 
during 1993 to 1996 is presented in Table 1. The total 
consumption of antibiotics in the county increased 
steadily until the second half of 1995, and 1995 was the 
year when the total consumption peaked. Total con- 
sumption showed a 13% decrease in 1996 compared 
to 1995. Some seasonal variations were seen, reflecting 
the winter periods, and this pattern was consistent for 
all antibiotic subgroups apart from sulfonamides and 
fluoroquinolones. The decrease was largest during the 
winter months. 
The decrease in consumption differed between the 
antibiotic groups, with the broad-spectrum antibiotics 
showing the steepest decline. For most of the groups 
there was a small decline during the last 6 months 
of 1995, but a very marked reduction was noticed 
immediately after 1 January 1996, as shown in Table 2. 
After withdrawal of reimbursement for tetracyclines, 
the use dropped by 42% during the first 3 months of 
1996. This tendency persisted during 1996. Although 
less marked, the same pattern was observed for fluoro- 
quinolones, macrolides and broad-spectrum penicillins 
but not for the cheaper narrow-spectrum penicillins. 
The consumption of penicillins, macrolides and tetra- 
cyclines in 1994-6 compared with 1993 (index=l00) 
is shown in Figure 1. 
DISCUSSION 
We found a major decrease in the prescription of 
antibiotics after the change in reimbursement policy. 
The decline started in the second half of 1995, but 
the prescription rate of antibiotics was considerably 
diminished from the beginning of 1996, when the 
new reimbursement policy was put into action. The 
reduction was most pronounced for the broad-spectrum 
antibiotics, especially for tetracyclines, for which reim- 
bursement was cut off. It seems prudent to assume that 
the change in reimbursement policy at least prompted 
the reduction in prescriptions of antibiotics. The 
intended changes attracted great attention from the 
public, and the mass media supported restrictive use 
of antibiotics. A change in the public opinion of what 
is good clinical practice has previously been shown 
to influence doctors’ behavior, and this might have 
enhanced the effect of the change in reimbursement 
[12]. The general practitioners were informed by the 
Danish National Board of Health prior to the reduction 
in reimbursement for antibiotics. This, together with 
the mass media attention, night explain the decrease in 
prescriptions of antibiotics prior to 1 January 1996, 
when the reimbursement was reduced. 
In this observational study without randomization, 
it is possible that not all the observed changes are caused 
by the intervention, and there is a risk of overestimating 
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Figure 1 Index for use of antibiotics 1994-6 compared with 1993 (index 1993=100) 
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the impact on prescribing [13]. However, the abrupt 
decrease in use of expensive broad-spectrum antibiotics 
by 1 January 1996, when reimbursement was reduced, 
indicates that the change in reimbursement policy is 
responsible. Our study is strengthened by complete 
coverage of a population's use of antibiotics in a 
community. Theoretically, the observed more res- 
trictive use of antibiotics could have resulted in 
hospitahzation and consequently an increased inpatient 
consumption of antibiotics, but the hospitals' use of 
antibiotics did not increase from 1995 to 1996. 
In Iceland, increased costs of antibiotics for patients 
have also proven effective in reducing consumption 
when connected with a campaign against misuse of 
antibiotics aimed at both physicians and the public [14]. 
The introduction of general limitations on reimburse- 
ment for drugs has also proven effective in reducing the 
consumption of antibiotics and at the same time 
introducing a shift from the more expensive broad- 
spectrum antibiotics to the cheaper narrow-spectrum 
penicillins, as we observe here [15]. The differential 
reimbursement policy instituted in Denmark may 
further enhance the shift in prescribing options which 
is desirable not only for economic reasons but also from 
an antibiotic resistance point of view. 
A number of strategies have been adopted to 
influence general practitioners' prescribing behavior 
with regard to antibiotics in Denmark. Since the 1970s, 
continuous medical educational programs and the 
medical press have advocated restrictive antibiotic 
usage. As part of this policy, broad-spectrum penicillins, 
tetracyclines, cephalosporins and fluoroquinolones have 
been reserved as secondary or tertiary choices. Ampi- 
cillin and trimethoprim-sulfamethoxazole have been 
targeted for campaigns emphasizing the risk of develop- 
ment of antibiotic resistance and side effects, respec- 
tively [ 161. Increasing erythromycin resistance among 
Staphylococcus aureus strains at a national level has 
been responded to by educational efforts and the 
introduction of reimbursement for p-lactamase-stable 
penicillins in 1991 [17]. 
The relative usage of antibiotic groups in this 
county reassures us that the national strategy of keeping 
consumption of newer, expensive and broad-spectrum 
antibiotics at a low level has been a success; for example, 
cephalosporins, which have never been subsidized, are 
hardly ever used in Danish primary care. Nevertheless, 
a steady annual increase was registered for all other 
antibiotic groups up to 1995. The increase had been 
especially marked for the macrolides, probably due to 
the introduction of a number of new macrolide drugs 
and a shift in preferences for the drugs. The adoption 
of new indications for antibiotics, such as combination 
therapy for treatment of Helicobacter pylori, may also 
seriously affect current patterns of antibiotic usage in 
primary care. What this means for the level of antibiotic 
resistance is &fficult to monitor using surveillance data 
&om hospital-based laboratories. General practitioners 
perform the majority of susceptibility tests in their 
offices, and submission of specimens is infrequent [8]. 
Hence, it is important to survey prescribing patterns of 
antibiotics in primary care but also to implement 
prospective survedance of antibiotic resistance and be 
ready to take action in the case of unfavorable develop- 
ments. 
In conclusion, it seems reasonable to take reim- 
bursement policies into consideration when trying to 
reduce the total consumption of antibiotics. When it 
is considered to be rational, a differential reimburse- 
ment might influence general practitioners' prescribing 
behavior towards antibiotics, with desirable ecological 
consequences. 
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